ALBANY, N.Y., March 3, 2017 /PRNewswire/ -- Albany
Molecular Research Inc. (NASDAQ: AMRI) announced today that
William S. Marth, President and
Chief Executive Officer, will present at the Barclays Global
Healthcare Conference on Thursday, March 16,
2017 at 10:45 a.m. ET. A live
audio webcast of the presentation can be accessed at AMRI's
Investor Relations website at
http://ir.amriglobal.com/events.cfm?CalendarID=2
The webcast will be archived for 90 days following the live
presentation.
About AMRI
Albany Molecular Research Inc. (AMRI)
is a global contract research and manufacturing organization that
has been working with the Life Sciences industry to improve patient
outcomes and the quality of life for more than two decades. With
locations in North America, Europe and Asia,
our key business segments include Discovery and Development
Services (DDS), Active Pharmaceutical Ingredients (API), Drug
Product (DP), and Fine Chemicals. For more information about AMRI,
please visit our website at www.amriglobal.com or follow us on
Twitter (@amriglobal).
Contacts
Investors
Patty Eisenhaur
AMRI Investor Relations
518.512.2936
patty.eisenhaur@amriglobal.com
Media
Gina Rothe
AMRI Communications
518-512-2512
gina.rothe@amriglobal.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/amri-to-present-at-barclays-global-healthcare-conference-300417019.html
SOURCE AMRI